High content screening: seeing is believing.

High content screening (HCS) combines the efficiency of high-throughput techniques with the ability of cellular imaging to collect quantitative data from complex biological systems. HCS technology is integrated into all aspects of contemporary drug discovery, including primary compound screening, post-primary screening capable of supporting structure-activity relationships, and early evaluation of ADME (absorption, distribution, metabolism and excretion)/toxicity properties and complex multivariate drug profiling. Recently, high content approaches have been used extensively to interrogate stem cell biology. Despite these dramatic advances, a number of significant challenges remain related to the use of more biology- and disease-relevant cell systems, the development of informative reagents to measure and manipulate cellular events, and the integration of data management and informatics.

[1]  Pamela A. Silver,et al.  A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. , 2003, Cancer cell.

[2]  O. Rabal,et al.  Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-Kinases* , 2009, The Journal of Biological Chemistry.

[3]  R. Damoiseaux,et al.  Integrated Chemical Genomics Reveals Modifiers of Survival in Human Embryonic Stem Cells , 2009, Stem cells.

[4]  Gerd Ulrich Nienhaus,et al.  Automated high content screening for phosphoinositide 3 kinase inhibition using an AKT 1 redistribution assay. , 2006, Combinatorial chemistry & high throughput screening.

[5]  Sheng Ding,et al.  Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. , 2010, Trends in pharmacological sciences.

[6]  Atsushi Miyawaki,et al.  Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression , 2008, Cell.

[7]  J. Jaiswal,et al.  Potentials and pitfalls of fluorescent quantum dots for biological imaging. , 2004, Trends in cell biology.

[8]  Minoru Yoshida,et al.  Real-time imaging of histone H4 hyperacetylation in living cells , 2009, Proceedings of the National Academy of Sciences.

[9]  Sheng Ding,et al.  A chemical approach to stem-cell biology and regenerative medicine , 2008, Nature.

[10]  R. Tsien,et al.  The Fluorescent Toolbox for Assessing Protein Location and Function , 2006, Science.

[11]  Paul A Johnston,et al.  Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform. , 2006, Methods in enzymology.

[12]  A. Dopazo,et al.  Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells , 2010, Oncogene.

[13]  Lasse Evensen,et al.  Mural Cell Associated VEGF Is Required for Organotypic Vessel Formation , 2009, PloS one.

[14]  John A. Tallarico,et al.  Integrating high-content screening and ligand-target prediction to identify mechanism of action. , 2008, Nature chemical biology.

[15]  David M. Sabatini,et al.  Building mammalian signalling pathways with RNAi screens , 2006, Nature Reviews Molecular Cell Biology.

[16]  Daniel Rauh,et al.  An Unbiased Cell Morphology–Based Screen for New, Biologically Active Small Molecules , 2005, PLoS biology.

[17]  D. S. Broomhead,et al.  Pulsatile Stimulation Determines Timing and Specificity of NF-κB-Dependent Transcription , 2009, Science.

[18]  H. Augustin,et al.  Combination of reverse and chemical genetic screens reveals angiogenesis inhibitors and targets. , 2009, Chemistry & biology.

[19]  Sheng Ding,et al.  A chemical platform for improved induction of human iPSCs , 2009, Nature Methods.

[20]  P. Bernardi,et al.  High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening , 2006, Archives of Toxicology.

[21]  Peter R. McDonald,et al.  A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells , 2008, Molecular Cancer Therapeutics.

[22]  B. Doble,et al.  The ground state of embryonic stem cell self-renewal , 2008, Nature.

[23]  S. Møller,et al.  Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 redistribution screen. , 2004, Assay and drug development technologies.

[24]  N. Socci,et al.  High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. , 2008, Cell stem cell.

[25]  Ruth R. Montgomery,et al.  RNA interference screen for human genes associated with West Nile virus infection , 2008, Nature.

[26]  Anne E Carpenter,et al.  A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen , 2006, Cell.

[27]  Lani F. Wu,et al.  Multidimensional Drug Profiling By Automated Microscopy , 2004, Science.

[28]  Tobias Meyer,et al.  A Transgenic Mouse Model for High Content, Cell Cycle Phenotype Screening in Live Primary Cells , 2007, Cell cycle.

[29]  L. Lederman.  High-content screening. , 2007, BioTechniques.

[30]  Marc Bickle,et al.  High-content screening: a new primary screening tool? , 2008, IDrugs : the investigational drugs journal.

[31]  Mitchell N. Cayen,et al.  A guide to drug discovery: Making Better Drugs: Decision Gates in Non-Clinical Drug Development , 2003, Nature Reviews Drug Discovery.

[32]  T. Garyantes,et al.  Identification of Gap Junction Blockers Using Automated Fluorescence Microscopy Imaging , 2003, Journal of biomolecular screening.

[33]  H. Schöler,et al.  Self-renewal of embryonic stem cells by a small molecule , 2006, Proceedings of the National Academy of Sciences.

[34]  S. Schreiber,et al.  A small molecule that directs differentiation of human ESCs into the pancreatic lineage. , 2009, Nature chemical biology.

[35]  M. Fenech.  In vitro micronucleus technique to predict chemosensitivity. , 2005, Methods in molecular medicine.

[36]  Christine C. Hudson,et al.  Quantitative Cell-Based High-Content Screening for Vasopressin Receptor Agonists Using Transfluor®Technology , 2005, Journal of biomolecular screening.

[37]  Peter V. Henstock,et al.  Cellular imaging predictions of clinical drug-induced liver injury. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  James P. Freyer,et al.  The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model , 2004, Journal of biomolecular screening.

[39]  J. Church.  Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2008, Pediatrics.

[40]  R. W. Draft,et al.  Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system , 2007, Nature.

[41]  P. Carmichael,et al.  Evaluation of an automated in vitro micronucleus assay in CHO-K1 cells. , 2007, Mutation research.

[42]  B. Stockwell.  Exploring biology with small organic molecules , 2004, Nature.

[43]  Weida Tong,et al.  Structure‐activity relationship approaches and applications , 2003, Environmental toxicology and chemistry.

[44]  C. Dobson.  Chemical space and biology , 2004, Nature.

[45]  B. K. Lundholt,et al.  Identification of RAS-Mitogen-Activated Protein Kinase Signaling Pathway Modulators in an ERF1 Redistribution® Screen , 2006, Journal of biomolecular screening.

[46]  Infection Through a Functional Genomic Screen Identification of Host Proteins Required for HIV , 2008 .

[47]  J. Ellenberg,et al.  High-throughput fluorescence microscopy for systems biology , 2006, Nature Reviews Molecular Cell Biology.

[48]  Lorenz M Mayr,et al.  Novel trends in high-throughput screening. , 2009, Current opinion in pharmacology.

[49]  Peter G Schultz,et al.  A synthetic small molecule that induces neuronal differentiation of adult hippocampal neural progenitor cells. , 2006, Angewandte Chemie.

[50]  W. Schoonen,et al.  High-throughput screening for analysis of in vitro toxicity. , 2009, EXS.

[51]  S. Mutka,et al.  Identification of nuclear export inhibitors with potent anticancer activity in vivo. , 2009, Cancer research.

[52]  Keith A Houck,et al.  High-content screening assay for activators of the Wnt/Fzd pathway in primary human cells. , 2005, Assay and drug development technologies.

[53]  Hidenori Akutsu,et al.  A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. , 2009, Cell stem cell.

[54]  Anne Kümmel,et al.  Integration of Multiple Readouts into the Z' Factor for Assay Quality Assessment , 2010, Journal of biomolecular screening.

[55]  D. L. Taylor,et al.  High content screening applied to large-scale cell biology. , 2004, Trends in biotechnology.

[56]  Lani F. Wu,et al.  Image-based multivariate profiling of drug responses from single cells , 2007, Nature Methods.

[57]  P. Schultz,et al.  A small molecule primes embryonic stem cells for differentiation. , 2009, Cell stem cell.

[58]  M. Mercola,et al.  High-throughput screening for modulators of stem cell differentiation. , 2006, Methods in enzymology.

[59]  Obdulia Rabal,et al.  An integrated one-step system to extract, analyze and annotate all relevant information from image-based cell screening of chemical libraries. , 2010, Molecular bioSystems.

[60]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[61]  Jing Zhang,et al.  High-content screening moves to the front of the line. , 2006, Drug discovery today.

[62]  C. Echeverri,et al.  Kinome-Wide RNAi Screen Implicates at Least 5 Host Hepatocyte Kinases in Plasmodium Sporozoite Infection , 2008, PLoS pathogens.

[63]  R. Zivin,et al.  Nile Red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis. , 2001, In vitro & molecular toxicology.

[64]  Cynthia L Adams,et al.  Compound classification using image-based cellular phenotypes. , 2006, Methods in enzymology.

[65]  Sheng Ding,et al.  A chemical approach to stem cell biology , 2008, Cell Research.

[66]  Stuart L. Schreiber,et al.  Small-molecule fluorophores to detect cell-state switching in the context of high-throughput screening. , 2008, Journal of the American Chemical Society.

[67]  Jeffrey Hung,et al.  Physiological indicators of cell function. , 2007, Methods in molecular biology.

[68]  B. Day,et al.  Cell-Based and Biochemical Structure-Activity Analyses of Analogs of the Microtubule Stabilizer Dictyostatin , 2008, Molecular Pharmacology.

[69]  W. Link,et al.  Using multiplexed regulation of luciferase activity and GFP translocation to screen for FOXO modulators , 2009, BMC Cell Biology.

[70]  W. Link,et al.  A Dual-Color Fluorescence-Based Platform to Identify Selective Inhibitors of Akt Signaling , 2008, PloS one.

[71]  Christopher P Austin,et al.  Automated High-Content Screening for Compounds That Disassemble the Perinucleolar Compartment , 2009, Journal of biomolecular screening.

[72]  Serge Batalov,et al.  Whole genome functional analysis identifies novel components required for mitotic spindle integrity in human cells , 2008, Genome Biology.

[73]  J. Dennis,et al.  A high-content chemical screen identifies ellipticine as a modulator of p53 nuclear localization , 2008, Apoptosis.

[74]  K. Yeow,et al.  Cellular imaging in drug discovery , 2006, Nature Reviews Drug Discovery.

[75]  S. Møller,et al.  Identification of Akt Pathway Inhibitors Using Redistribution Screening on the FLIPR and the IN Cell 3000 Analyzer , 2005, Journal of biomolecular screening.

[76]  A. Hoffman,et al.  High-throughput confocal microscopy for beta-arrestin-green fluorescent protein translocation G protein-coupled receptor assays using the Evotec Opera. , 2006, Methods in enzymology.

[77]  Paul A Johnston,et al.  High-throughput automated confocal microscopy imaging screen of a kinase-focused library to identify p38 mitogen-activated protein kinase inhibitors using the GE InCell 3000 analyzer. , 2009, Methods in molecular biology.

[78]  W. Link,et al.  A novel imaging‐based high‐throughput screening approach to anti‐angiogenic drug discovery , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[79]  Wolfgang Link,et al.  Chemical Genetic Analysis of FOXO Nuclear–Cytoplasmic Shuttling by Using Image‐Based Cell Screening , 2008, Chembiochem : a European journal of chemical biology.

[80]  Sheng Ding,et al.  A chemical approach to stem cell biology. , 2007 .

[81]  D. Bojanic,et al.  Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. , 2005, Drug discovery today.

[82]  R G Ulrich,et al.  Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes(1). , 2001, Biochemical pharmacology.

[83]  W. Link,et al.  An HTS approach to screen for antagonists of the nuclear export machinery using high content cell-based assays. , 2007, Assay and drug development technologies.

[84]  Robert H Singer,et al.  Gene expression and the myth of the average cell. , 2003, Trends in cell biology.